S-303 Red Blood Cells (RBCs) - Test + Conventional, untreated red blood cells (RBCs) - Control
Phase 3Completed 0 views this week 0 watching💤 Quiet
Interest: 30/100
30
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Focus:Use of S303 RBCs in Patients With Acute Anemia
Conditions
Focus:Use of S303 RBCs in Patients With Acute Anemia
Trial Timeline
Apr 1, 2013 → Oct 1, 2014
NCT ID
NCT01716923About S-303 Red Blood Cells (RBCs) - Test + Conventional, untreated red blood cells (RBCs) - Control
S-303 Red Blood Cells (RBCs) - Test + Conventional, untreated red blood cells (RBCs) - Control is a phase 3 stage product being developed by Cerus for Focus:Use of S303 RBCs in Patients With Acute Anemia. The current trial status is completed. This product is registered under clinical trial identifier NCT01716923. Target conditions include Focus:Use of S303 RBCs in Patients With Acute Anemia.
Hype Score Breakdown
Clinical
17
Activity
8
Company
5
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01716923 | Phase 3 | Completed |